Cervical cancer is the second most common cause of
cancer death in women worldwide.
Lysophosphatidic acid (LPA) level has been found significantly increased in the serum of patients with ovarian, cervical, and
colon cancers. LPA level in
cervical cancer patients is significantly higher than in healthy controls.
LPA receptors were found highly expressed in
cervical cancer cells, suggesting LPA may play a role in the development of
cervical cancer. The aim of this study is to investigate the effect of LPA on the apoptosis induced by
cisplatin (DDP) in
cervical cancer cell line and the underlying changes in signaling pathways. Our study found that
cisplatin induced apoptosis of Hela cell through inhibiting expression of Bcl-2, upregulating the expression of Bax, Fas-L, and the
enzyme activity of
caspase-3 (p < 0.05); LPA significantly provided protection against the apoptosis induced by
cisplatin by inhibiting the above alterations in apoptotic factor caused by
cisplatin (p < 0.05). Moreover, PI3K/AKT pathway was found to be important for the LPA antiapoptosis effect, and administration of PI3K/AKT partially reversed the LPA-mediated protection against
cisplatin-induced apoptosis (p < 0.05). These findings have shed new lights on the LPA bioactivity in
cervical cancer cells and pointed to a possible sensitization scheme through combined administration of PI3K inhibitor and
cisplatin for better treatment of
cervical cancer patients, especially those with elevated LPA levels.